share_log
Benzinga ·  05/02 07:55

Sagimet Biosciences Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced a $32 Price Target

继HC Wainwright & Co之后,Sagimet Biosciences的股价走高以买入评级开始对该股进行报道,并宣布了32美元的目标股价

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发